Mylan Reports Results, Announces Acquisition

Mylan (NASDAQ: MYL  ) has reported improved numbers in its fiscal Q4 and 2012 results, and it also shared news of an acquisition. For the quarter, the generic-drug company's revenue was $1.7 billion, against $1.5 billion in the same period the previous year. Net profit came in at $267 million ($0.65 per diluted share), which trumped Q4 2011's figure of $227 million ($0.53).

For the full year, the top line totaled $6.8 billion and the company netted $1.09 billion ($2.59 diluted EPS), against 2011's sales of $6.1 billion and $893 million ($2.04) net profit.

Mylan also proffered guidance for its fiscal 2013. It believes it will take in $7.0 billion-$7.4 billion in revenue and post a net profit of $1.06 billion-$1.18 billion ($2.75-$2.95 diluted EPS) for the year.

Separately, the company said it is to acquire Agila, a supplier of injectable products, from India-based Strides Arcolab. The price is $1.6 billion in cash, and the transaction is expected to be completed in Q4 2013, assuming regulatory approvals and "certain closing conditions," according to Mylan.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2283675, ~/Articles/ArticleHandler.aspx, 9/22/2014 2:19:47 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement